tiprankstipranks
HUTCHMED (China) Limited (DE:H7T2)
FRANKFURT:H7T2
Germany Market
H7T2
HUTCHMED (China)
RESEARCH TOOLSreports

HUTCHMED (China) (H7T2) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

H7T2 Analyst Ratings

Moderate Buy
11Ratings
Moderate Buy
8 Buy
3 Hold
0 Sell
Based on 11 analysts giving stock ratings to
HUTCHMED
(China)
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

H7T2 Stock 12 Month Forecast

Average Price Target

€3.17
▲(72.96% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for HUTCHMED (China) in the last 3 months. The average price target is €3.17 with a high forecast of €4.12 and a low forecast of €2.20. The average price target represents a 72.96% change from the last price of €1.83.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"€0","5":"€5","1.25":"€1.25","2.5":"€2.5","3.75":"€3.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":4.1226458,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€4.12</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.165215229090909,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€3.17</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.20168,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€2.20</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1.25,2.5,3.75,5],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.81,1.9878958307692307,2.165791661538462,2.3436874923076925,2.521583323076923,2.699479153846154,2.8773749846153844,3.0552708153846155,3.233166646153846,3.411062476923077,3.588958307692308,3.7668541384615386,3.9447499692307693,{"y":4.1226458,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.81,1.9142473253146854,2.018494650629371,2.122741975944056,2.226989301258741,2.3312366265734266,2.435483951888112,2.5397312772027973,2.6439786025174823,2.7482259278321677,2.852473253146853,2.956720578461538,3.0609679037762234,{"y":3.165215229090909,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.81,1.8401292307692307,1.8702584615384616,1.9003876923076923,1.9305169230769232,1.960646153846154,1.9907753846153846,2.0209046153846155,2.0510338461538464,2.081163076923077,2.111292307692308,2.1414215384615387,2.171550769230769,{"y":2.20168,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.42,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.5,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.34,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.38,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.14,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.38,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.3,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.32,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.14,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.87,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.73,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.81,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€4.12Average Price Target€3.17Lowest Price Target€2.20
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
CICC Analyst forecast on DE:H7T2
Unknown Analyst
CICC
Not Ranked
CICC
€2.62→€2.86
Buy
56.40%
Upside
Reiterated
08/18/26
CICC Sticks to Its Buy Rating for HUTCHMED (China) (HCM)
Orient Securities Analyst forecast on DE:H7T2
Unknown Analyst
Orient Securities
Not Ranked
Orient Securities
€3.28
Buy
79.20%
Upside
Reiterated
08/18/26
Orient Securities Keeps Their Buy Rating on HUTCHMED (China) (HCM)
Citic Securities Analyst forecast on DE:H7T2
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
€3.96
Buy
116.56%
Upside
Reiterated
08/14/26
Citic Securities Sticks to Their Buy Rating for HUTCHMED (China) (HCM)
Daiwa Analyst forecast on DE:H7T2
Unknown Analyst
Daiwa
Not Ranked
Daiwa
€2.2
Hold
20.31%
Upside
Downgraded
08/12/26
HUTCHMED (China) (HCM) was downgraded to a Hold Rating at Daiwa
BOCOM International Holdings Company Analyst forecast on DE:H7T2
Unknown Analyst
BOCOM International Holdings Company
Not Ranked
BOCOM International Holdings Company
€4.12
Buy
125.28%
Upside
Reiterated
08/03/26
HUTCHMED (China) (HCM) Gets a Buy from BOCOM International Holdings Company
UBS Analyst forecast on DE:H7T2
Unknown Analyst
UBS
Not Ranked
UBS
€3.75→€3.25
Buy
77.46%
Upside
Reiterated
07/31/26
UBS Remains a Buy on HUTCHMED (China) (HCM)
UOB Kay Hian Analyst forecast on DE:H7T2
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
€2.86
Buy
56.40%
Upside
Reiterated
07/31/26
UOB Kay Hian Remains a Buy on HUTCHMED (China) (HCM)
Guotai Haitong Analyst forecast on DE:H7T2
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
€3.92
Buy
114.03%
Upside
Reiterated
07/31/26
Guotai Haitong Keeps Their Buy Rating on HUTCHMED (China) (HCM)
Huatai Securities Analyst forecast on DE:H7T2
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
€3.61
Buy
97.43%
Upside
Reiterated
07/31/26
Huatai Securities Sticks to Their Buy Rating for HUTCHMED (China) (HCM)
Goldman Sachs Analyst forecast on DE:H7T2
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
€2.4
Hold
31.38%
Upside
Reiterated
07/30/26
Morgan Stanley Analyst forecast on DE:H7T2
Jack Lin
Morgan Stanley
Morgan Stanley
€2.34
Hold
28.13%
Upside
Reiterated
05/28/26
Morgan Stanley Reaffirms Their Hold Rating on HUTCHMED (China) (HCM)
GF Securities Analyst forecast on DE:H7T2
Unknown Analyst
GF Securities
Not Ranked
GF Securities
€3.57
Buy
95.02%
Upside
Reiterated
03/23/26
HUTCHMED (China) (HCM) Gets a Buy from GF Securities
SPDB Analyst forecast on DE:H7T2
Unknown Analyst
SPDB
Not Ranked
SPDB
€3.08
Buy
68.43%
Upside
Reiterated
03/13/26
HUTCHMED (China) (HCM) Receives a Buy from SPDB
CLSA Analyst forecast on DE:H7T2
Unknown Analyst
CLSA
Not Ranked
CLSA
€3.35
Buy
82.87%
Upside
Reiterated
03/06/26
CLSA Keeps Their Buy Rating on HUTCHMED (China) (HCM)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
CICC Analyst forecast on DE:H7T2
Unknown Analyst
CICC
Not Ranked
CICC
€2.62→€2.86
Buy
56.40%
Upside
Reiterated
08/18/26
CICC Sticks to Its Buy Rating for HUTCHMED (China) (HCM)
Orient Securities Analyst forecast on DE:H7T2
Unknown Analyst
Orient Securities
Not Ranked
Orient Securities
€3.28
Buy
79.20%
Upside
Reiterated
08/18/26
Orient Securities Keeps Their Buy Rating on HUTCHMED (China) (HCM)
Citic Securities Analyst forecast on DE:H7T2
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
€3.96
Buy
116.56%
Upside
Reiterated
08/14/26
Citic Securities Sticks to Their Buy Rating for HUTCHMED (China) (HCM)
Daiwa Analyst forecast on DE:H7T2
Unknown Analyst
Daiwa
Not Ranked
Daiwa
€2.2
Hold
20.31%
Upside
Downgraded
08/12/26
HUTCHMED (China) (HCM) was downgraded to a Hold Rating at Daiwa
BOCOM International Holdings Company Analyst forecast on DE:H7T2
Unknown Analyst
BOCOM International Holdings Company
Not Ranked
BOCOM International Holdings Company
€4.12
Buy
125.28%
Upside
Reiterated
08/03/26
HUTCHMED (China) (HCM) Gets a Buy from BOCOM International Holdings Company
UBS Analyst forecast on DE:H7T2
Unknown Analyst
UBS
Not Ranked
UBS
€3.75→€3.25
Buy
77.46%
Upside
Reiterated
07/31/26
UBS Remains a Buy on HUTCHMED (China) (HCM)
UOB Kay Hian Analyst forecast on DE:H7T2
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
€2.86
Buy
56.40%
Upside
Reiterated
07/31/26
UOB Kay Hian Remains a Buy on HUTCHMED (China) (HCM)
Guotai Haitong Analyst forecast on DE:H7T2
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
€3.92
Buy
114.03%
Upside
Reiterated
07/31/26
Guotai Haitong Keeps Their Buy Rating on HUTCHMED (China) (HCM)
Huatai Securities Analyst forecast on DE:H7T2
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
€3.61
Buy
97.43%
Upside
Reiterated
07/31/26
Huatai Securities Sticks to Their Buy Rating for HUTCHMED (China) (HCM)
Goldman Sachs Analyst forecast on DE:H7T2
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
€2.4
Hold
31.38%
Upside
Reiterated
07/30/26
Morgan Stanley Analyst forecast on DE:H7T2
Jack Lin
Morgan Stanley
Morgan Stanley
€2.34
Hold
28.13%
Upside
Reiterated
05/28/26
Morgan Stanley Reaffirms Their Hold Rating on HUTCHMED (China) (HCM)
GF Securities Analyst forecast on DE:H7T2
Unknown Analyst
GF Securities
Not Ranked
GF Securities
€3.57
Buy
95.02%
Upside
Reiterated
03/23/26
HUTCHMED (China) (HCM) Gets a Buy from GF Securities
SPDB Analyst forecast on DE:H7T2
Unknown Analyst
SPDB
Not Ranked
SPDB
€3.08
Buy
68.43%
Upside
Reiterated
03/13/26
HUTCHMED (China) (HCM) Receives a Buy from SPDB
CLSA Analyst forecast on DE:H7T2
Unknown Analyst
CLSA
Not Ranked
CLSA
€3.35
Buy
82.87%
Upside
Reiterated
03/06/26
CLSA Keeps Their Buy Rating on HUTCHMED (China) (HCM)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering HUTCHMED (China)

3 Months
xAi Health Care GBTipRanks - xAI
Success Rate
0/2 ratings generated profit
0%
Average Return
-6.00%
Copying xAi Health Care GB's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -6.00% per trade.
1 Year
xAi Health Care GBTipRanks - xAI
Success Rate
0/2 ratings generated profit
0%
Average Return
-6.00%
Copying xAi Health Care GB's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -6.00% per trade.
2 Years
xAi Health Care GBTipRanks - xAI
Success Rate
0/2 ratings generated profit
0%
Average Return
-6.00%
Copying xAi Health Care GB's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -6.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

H7T2 Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
2
3
2
6
7
Buy
8
8
0
1
4
Hold
0
1
1
2
2
Sell
1
1
0
0
0
Strong Sell
0
0
0
0
0
total
11
13
3
9
13
In the current month, H7T2 has received 11 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. H7T2 average Analyst price target in the past 3 months is 3.17.
Each month's total comprises the sum of three months' worth of ratings.

H7T2 Financial Forecast

H7T2 Earnings Forecast

Next quarter’s earnings estimate for H7T2 is €0.04 with a range of €0.03 to €0.05. The previous quarter’s EPS was €0.02. H7T2 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year H7T2 has Performed in-line its overall industry.
Next quarter’s earnings estimate for H7T2 is €0.04 with a range of €0.03 to €0.05. The previous quarter’s EPS was €0.02. H7T2 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year H7T2 has Performed in-line its overall industry.

H7T2 Sales Forecast

Next quarter’s sales forecast for H7T2 is €284.08M with a range of €259.33M to €305.49M. The previous quarter’s sales results were €239.57M. H7T2 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year H7T2 has Performed in-line its overall industry.
Next quarter’s sales forecast for H7T2 is €284.08M with a range of €259.33M to €305.49M. The previous quarter’s sales results were €239.57M. H7T2 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year H7T2 has Performed in-line its overall industry.

H7T2 Stock Forecast FAQ

What is DE:H7T2’s average 12-month price target, according to analysts?
Based on analyst ratings, HUTCHMED (China) Limited’s 12-month average price target is 3.17.
    What is DE:H7T2’s upside potential, based on the analysts’ average price target?
    HUTCHMED (China) Limited has 72.96% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is HUTCHMED (China) Limited a Buy, Sell or Hold?
          HUTCHMED (China) Limited has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 3 hold ratings and 0 sell ratings.
            What is HUTCHMED (China) Limited’s share price target?
            The average share price target for HUTCHMED (China) Limited is 3.17. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €4.12 ,and the lowest forecast is €2.20. The average share price target represents 72.96% Increase from the current price of €1.83.
              What do analysts say about HUTCHMED (China) Limited?
              HUTCHMED (China) Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of HUTCHMED (China) Limited?
                To buy shares of DE:H7T2, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.